. The following Ô¨Åve issues/questions are
addressed:
1. Is CEA recommended over maximal medical therapy
for asymptomatic carotid stenosis in low surgical risk
patients?
2. Is CEA recommended over transfemoral CAS in low
surgical risk patients for symptomatic carotid artery
stenosis of greater than 50%?
3. What is the optimal timing of carotid intervention in
patients presenting with acute stroke?
4. Screening for